EVM Contributes To Council Of Europe Hearing On "The Handling Of The H1N1 Pandemic: More Transparency Needed?"

Main Category: Swine Flu
Also Included In: Flu / Cold / SARS;  Public Health;  Infectious Diseases / Bacteria / Viruses
Article Date: 27 Jan 2010 - 0:00 PDT

email to a friend   printer friendly   opinions  

The European Vaccine Manufacturers group (EVM) welcomed the opportunity to address today's Council of Europe Health Committee hearing on 'The handling of the H1N1 pandemic: more transparency needed?' EVM was pleased to provide information on industry's role in helping combat pandemic influenza, and sought to address many of the misunderstandings that exist regarding the pandemic planning process. The EVM rejected allegations of inappropriate behaviour by vaccine producers during the response to H1N1 influenza, and provided additional clarity in three key areas:

1. Vaccine manufacturers responded to the requirements of public health authorities and national governments;

2. Industry responded quickly and effectively and was able to deliver vaccines ordered by governments;

3. Pandemic vaccines were properly developed and tested, and have been safely used in millions of European citizens.

Source
European Vaccine Manufacturers

• Additional
• References
• Citations